Creative Capital Management Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6K Buy
286
+33
+13% +$2.89K 0.01% 222
2026
Q1
$22.9K Hold
253
– – 0.01% 168
2025
Q4
$22.8K Hold
253
– – 0.01% 167
2025
Q3
$24.9K Hold
253
– – 0.01% 157
2025
Q2
$23.1K Hold
253
– – 0.01% 166
2025
Q1
$28.6K Hold
253
– – 0.01% 134
2024
Q4
$26.7K Hold
253
– – 0.01% 138
2024
Q3
$27.3K Buy
253
+55
+28% +$6K 0.01% 121
2024
Q2
$21.5K Hold
198
– – 0.01% 126
2024
Q1
$26.1K Hold
198
– – 0.01% 109
2023
Q4
$24.1K Hold
198
– – 0.01% 114
2023
Q3
$22.2K Hold
198
– – 0.02% 117
2023
Q2
$28.8K Hold
198
– – 0.02% 102
2023
Q1
$25.6K Hold
198
– – 0.02% 118
2022
Q4
$25K Buy
+198
New +$23K 0.02% 97

Other funds holding ZBH

Creative Capital Management Investments's ZBH Position: Q2 2026 in Review

Creative Capital Management Investments increased its Zimmer Biomet (ZBH) stake by 13% in Q2 2026, buying an estimated $2.89K and bringing the position to 286 shares worth $24.6K. The position accounts for 0.01% of the portfolio, ranked #222.

Creative Capital Management Investments first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $28.8K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Creative Capital Management Investments held 286 shares of Zimmer Biomet worth $24.6K as of Q2 2026.
  • Creative Capital Management Investments bought 33 Zimmer Biomet shares in Q2 2026, an estimated $2.89K.
  • Zimmer Biomet made up 0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #222 holding.
  • Creative Capital Management Investments first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
  • Creative Capital Management Investments's Zimmer Biomet position peaked at $28.8K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.